Platelet-Rich Plasma Therapy for Telogen Effluvium: A Comprehensive Evaluation of Efficacy and Safety
April 2024
New to Platelet-Rich Plasma? There is a guide in the encyclopedia. Read the guide → 
Studysummary This study observed that combining PRP and Tressfix Serum significantly improved hair regrowth and reduced microRNA expression linked to Chronic Telogen Effluvium compared to using either treatment alone.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated the efficacy and safety of combining platelet-rich plasma (PRP) with Tressfix Serum in treating chronic telogen effluvium (TE) in a randomized clinical trial with 60 patients aged 20-40. Participants were divided into three groups: Group A (PRP + Tressfix Serum), Group B (PRP alone), and Group C (Tressfix Serum alone). Group A showed the most significant improvement in hair regrowth and reduction in hair shedding, with a notable decrease in microRNA expression related to TE, particularly hsa-mir-223 and hsa-mir-212. The combination therapy was more effective than individual treatments, suggesting a promising approach for TE. However, the study's small sample size and lack of long-term follow-up indicate the need for further research with larger populations to confirm these findings.
